#1 Clinical Trials Search in Europe

Placebo

Placebos play a crucial role in clinical trials, serving as a control to evaluate the effectiveness of new drugs and treatments. This article explores the use of placebos in various clinical trials, their importance in medical research, and how they contribute to our understanding of drug efficacy and patient outcomes.

Table of Contents

What is Placebo?

A placebo is an inactive substance or treatment that looks identical to the real medication being tested in a clinical trial[1]. It’s often referred to as a “sugar pill” because it contains no active ingredients and has no direct therapeutic effect[1]. Placebos are crucial in medical research to help determine the true effects of new treatments.

How Placebo is Used in Clinical Trials

In clinical trials, placebos are used as a comparison to the active treatment being studied. Patients are typically randomly assigned to receive either the real treatment or the placebo, without knowing which they are getting. This helps researchers determine if the actual medication is more effective than no treatment at all[2][3].

For example, in a study on a new diabetes medication, some patients received the real drug while others got a placebo that looked identical[4]. This allows researchers to compare the effects and see if the real drug truly makes a difference.

Medical Conditions Studied with Placebo

Placebos are used in research for a wide variety of medical conditions. Some examples from the provided studies include:

  • Restless Legs Syndrome (RLS): A condition causing uncomfortable sensations in the legs and an urge to move them[5]
  • Bacterial Vaginosis: An infection causing abnormal vaginal discharge[3]
  • Diabetic Peripheral Neuropathic Pain: Nerve pain caused by diabetes[1]
  • Osteoarthritis: Joint pain and stiffness typically affecting older adults[6]
  • Cocaine Dependence: Addiction to the drug cocaine[7]

How Placebo is Administered

Placebos are designed to mimic the real treatment being studied. They can be given in various forms, including:

  • Oral tablets or capsules[4]
  • Vaginal tablets[3]
  • Creams applied to the skin[8]
  • Injections[9]

The dosing schedule for placebos also matches that of the real treatment. For instance, in one study, participants took the placebo orally twice a day for up to 51 days[1].

Safety and Side Effects

Since placebos don’t contain active ingredients, they generally don’t cause direct side effects. However, people taking placebos may experience what’s known as the “placebo effect” – feeling better simply because they believe they’re receiving treatment[5].

In clinical trials, researchers carefully monitor all participants for any adverse events (negative health effects), regardless of whether they’re receiving the real treatment or placebo[1]. This helps ensure patient safety and provides valuable information about the treatment being studied.

Effectiveness of Placebo

While placebos don’t have direct therapeutic effects, the placebo effect can be powerful. In some studies, a significant number of patients taking placebos report improvements in their symptoms[5].

For example, in a study on restless legs syndrome, researchers looked at how many patients taking the placebo reported feeling “much improved” or “very much improved” after treatment[5]. This helps them understand how much of the real treatment’s effect might be due to patients’ expectations rather than the medication itself.

It’s important to note that the use of placebos in research doesn’t mean that the conditions being studied aren’t real or serious. Rather, placebos help ensure that new treatments are truly effective before they’re approved for widespread use.

Aspect Description
Purpose of Placebos Used as a control to evaluate the effectiveness of new drugs and treatments
Types of Studies Randomized, double-blind, placebo-controlled trials across various medical conditions
Duration Varies from single-night studies to several weeks or months
Conditions Studied COVID-19, hypospadias, ulcer hemorrhage, HCV infection, Parkinson’s disease, tinea pedis, insomnia
Outcome Measures Clinical improvement, adverse events, pharmacokinetics, pharmacodynamics
Placebo Administration Oral tablets, intravenous infusions, topical applications
Ethical Considerations Informed consent, non-deceptive placebo use in some studies

FAQ

  • What is a placebo? A placebo is an inactive substance or treatment that looks identical to the active drug or treatment being tested in a clinical trial. It typically has no known medical benefits but is used as a control to compare against the active treatment.
  • Why are placebos used in clinical trials? Placebos are used to help determine the true effect of a new drug or treatment. By comparing the results of patients who receive the active treatment to those who receive the placebo, researchers can better understand the efficacy and safety of the drug being studied.
  • Can placebos have real effects on patients? Yes, placebos can sometimes produce real physiological or psychological effects, known as the 'placebo effect.' This can include improvements in symptoms or condition, even though the placebo contains no active ingredients.
  • Are patients always unaware that they're receiving a placebo? In most clinical trials, patients are not told whether they're receiving the active treatment or a placebo. However, some studies, like the insomnia trial mentioned, explore the effects of non-deceptive placebo use, where patients are informed they are receiving a placebo.
  • How long do placebo-controlled trials typically last? The duration of placebo-controlled trials can vary widely depending on the condition being studied and the drug being tested. In the examples provided, trials ranged from a single night (in the insomnia study) to several weeks or months in other studies.

Ongoing Clinical Trials on Placebo

  • Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

    Recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Latvia Poland +2

  • A Study Comparing Melatonin versus Placebo for Mood Stabilization in Patients with Bipolar Disorder

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Poland +2

  • Study of Everolimus and Resistance Training to Improve Bone Formation in Healthy Postmenopausal Women

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Norway Portugal Spain Sweden

  • Study on the Effects of Roxadustat and Placebo on Cardiovascular Risk Factors and Metabolic Syndrome in Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on Fecal Microbiota Transfer for Better Diabetes Control in Adults with Type 2 Diabetes After Bariatric Surgery

    Recruiting

    1 1
    Investigated drugs:
    France

  • Study on Fecal Microbiota Transplantation for Crohn’s Disease Patients in Remission After Stopping Anti-TNF Therapy

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Oral Fecal Microbiota Transplantation in Patients Colonized with Multi-Drug Resistant Bacteria

    Recruiting

    1 1
    Investigated drugs:
    France

Glossary

  • Placebo: An inactive substance or treatment that looks identical to the active drug or treatment being tested, used as a control in clinical trials.
  • Double-blind: A study design where neither the participants nor the researchers know who is receiving the active treatment or the placebo.
  • Randomized controlled trial: A type of clinical study where participants are randomly assigned to receive either the treatment being tested or a placebo.
  • Efficacy: The ability of a drug or treatment to produce the desired effect.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Pharmacodynamics (PD): The study of how a drug affects the body, including its mechanism of action and relationship between drug concentration and effect.
  • Adverse event: Any unfavorable or unintended sign, symptom, or disease associated with the use of a medical treatment.
  • Clinical improvement: A measurable improvement in a patient's condition or symptoms as a result of treatment.
  • Non-deceptive placebo: The use of placebos in clinical trials where patients are informed that they are receiving an inactive treatment.

References

  1. https://clinicaltrials.gov/study/NCT02156336
  2. https://clinicaltrials.gov/study/NCT01120665
  3. https://clinicaltrials.gov/study/NCT02376972
  4. https://clinicaltrials.gov/study/NCT01006018
  5. https://clinicaltrials.gov/study/NCT00365352
  6. https://clinicaltrials.gov/study/NCT04108832
  7. https://clinicaltrials.gov/study/NCT00783276
  8. https://clinicaltrials.gov/study/NCT01763307
  9. https://clinicaltrials.gov/study/NCT01356862